Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.
Long Island University and Omnicell Launch Center for Innovative Medication Management streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Lathrop GPM LLP add four lawyers to the Intellectual Property Practice Group in Boston and Minneapolis. Partner Lisa Hillman, Ph.D., Counsel.